AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26537941
Drug: Lipid-based nutrient
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid-based nutrient supplements (LNSs) with antiretrovirals
Trial: 22017782
Drug: Naproxen 275
RxNorm normalized name: naproxen sodium 275 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen 275 mg every 12 hours for 120 hours
Trial: 22017782
Drug: Placebo 275
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo 275 mg every 12 hours for 120 hours
Trial: 17634178
Drug: Lingual 24%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lingual 24% sucrose (0.5-2 ml varying with body weight) administered 2 min before nasogastric tube insertion
Trial: 17634178
Drug: Water placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water placebo (0.5-2 ml varying with body weight) administered 2 min before nasogastric tube insertion
Trial: 12871445
Drug: Bemiparin (3500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bemiparin (3500 IU anti-factor Xa, first dose 6 h after surgery)
Trial: 12871445
Drug: Enoxaparin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin (40 mg, first dose 12 h before surgery)
Trial: 28363933
Drug: Melatonin 0.5
RxNorm normalized name: melatonin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 0.5 mg
Trial: 10594526
Drug: Melatonin 5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 5.0 mg
Trial: 392853
Drug: L-lysine monohydrochloride,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-lysine monohydrochloride, 1,000 mg daily for five days
Trial: 25822924
Drug: Nebulized ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized ketamine (2 mg/kg)
Trial: 25822924
Drug: Nebulized dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized dexmedetomidine (2 μg/kg)
Trial: 25822924
Drug: Combined nebulized
RxNorm normalized name: Hydra-Neb
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined nebulized dexmedetomidine and ketamine (1 μg/kg + 1 mg/kg)
Trial: 23818535
Drug: Usual treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual treatment alone (Control)
Trial: 21114602
Drug: 12 Oral-lyn
RxNorm normalized name: Pediatex 12 Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 Oral-lyn puffs (1 puff = 1 s.c. rapid insulin UI), split into two doses before and after OGTT
Trial: 21114602
Drug: 6 Oral-lyn
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 Oral-lyn puffs (used in group C)
Trial: 19182178
Drug: Social activity
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Social activity therapy (SAT)
Trial: 17483968
Drug: 0.1% isotretinoin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% isotretinoin gel for 4 months
Trial: 9579836
Drug: PBPC+G‐CSF (n
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PBPC+G‐CSF (n = 11)
Trial: 8043974
Drug: Low-dose prednisolone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose prednisolone (0.5 mg/kgBW daily for 1 week, then tapered by 0.1 mg/kg BW/week for 1 month) and chlorambucil (0.12 mg/kgBW daily) administered during months 1-6.
Trial: 8043974
Drug: Low-dose prednisolone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose prednisolone and chlorambucil therapy
Trial: 3052785
Drug: Metoclopramide (MCP)
DrugBank: Metoclopramide (DB01233)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metoclopramide (MCP) alone (total dose, 6 mg/kg)
Trial: 3052785
Drug: Metoclopramide (MCP)
DrugBank: Metoclopramide (DB01233)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metoclopramide (MCP) plus Dexamethasone (DMS) (total dose, 60 mg)
Trial: 30500309
Drug: Five weekly
RxNorm normalized name: fivehorn smotherweed pollen extract
DrugBank: Bassia hyssopifolia pollen (DB10941)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Five weekly cellphone-delivered sessions of stigma and alcohol-enhanced behavioural self-regulation counselling
Trial: 25522265
Drug: Broccoli sprouts
RxNorm normalized name: broccoli sprout extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broccoli sprouts (200 μmol SFN daily)
Trial: 25522265
Drug: Myrosinase-treated broccoli
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Myrosinase-treated broccoli sprout extract (BSE) (200 μmol SFN daily)
Trial: 25522265
Drug: Twice daily
RxNorm normalized name: CAPSULE, TWICE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice daily dosing (two 100-μmol doses taken 12 h apart)
Trial: 25522265
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose (200 μmol SFN)
Trial: 20929915
Drug: Intravenous ferric
RxNorm normalized name: Ferric Oxide
DrugBank: Ferric oxide (DB11576)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ferric carboxymaltose 1000 mg over 15 min (with up to two additional doses of 500 mg at 2-week intervals)
Trial: 20929915
Drug: Intravenous ferric
RxNorm normalized name: Ferric Oxide
DrugBank: Ferric oxide (DB11576)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ferric carboxymaltose 1000 mg over 15 min
Trial: 20929915
Drug: Oral ferrous
RxNorm normalized name: ferrous fumarate Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ferrous sulphate 325 mg thrice daily for a total of 195 mg elemental iron daily for 56 days
Trial: 18236203
Drug: 8-week treatment
RxNorm normalized name: Weeks and Leo Complete Lice Treatment KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8-week treatment group (n = 10)
Trial: 9532649
Drug: Ascolong (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ascolong (12.5 mg) administered once or regularly for 2 weeks
Trial: 9532649
Drug: Ascolong (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ascolong (12.5 mg)
Trial: 8057111
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose levodopa-carbidopa (<= 600/150 mg/day)
Trial: 8057111
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose bromocriptine (<= 30 mg/day)
Trial: 2970159
Drug: 1% clindamycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% clindamycin phosphate in alcoholic solution
Trial: 28150367
Drug: 5% benzoyl
RxNorm normalized name: BENZOYL PEROXIDE 2.5 g in 100 mL TOPICAL SOAP [Benzoyl Acne Wash -2.5% Benzoyl Peroxide]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% benzoyl peroxide gel
Trial: 26699542
Drug: Chinese Herbal
RxNorm normalized name: GINGER 28 mg in 100 mL TOPICAL OIL [Pain Relief Honzo Seika Chinese Herbal Aroma Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese Herbal Medicine (CHM)
Trial: 26699542
Drug: Non-Chinese Herbal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-Chinese Herbal Medicine (non-CHM)
Trial: 23152361
Drug: Irsogladine maleate
RxNorm normalized name: maleate
DrugBank: Irsogladine (DB13056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irsogladine maleate (IM) 4 mg/day for 14 days
Trial: 19189989
Drug: Hormone replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone replacement therapy (HRT) - Tibolone (n = 25)
Trial: 10904853
Drug: Treatment according
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment according to the etiology of the disease (specific treatment not detailed in the abstract)
Trial: 10904853
Drug: Placebo (not
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (not explicitly mentioned but implied as part of the American Myocarditis Treatment Trial)
Trial: 9488974
Drug: Zidovudine or
RxNorm normalized name: zidovudine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zidovudine or didanosine before and after treatment
Trial: 7870965
Drug: Cocaine administered
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine administered alone (4-96 mg/70 kg)
Trial: 7870965
Drug: Alcohol administered
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol administered alone (0-1.0 g/kg)
Trial: 25887111
Drug: Ramelteon 8
RxNorm normalized name: ramelteon 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramelteon 8 mg before bedtime for 4 weeks
Trial: 22925428
Drug: Reimbursement for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reimbursement for smoking cessation treatment
Trial: 15948996
Drug: Oral pimecrolimus
RxNorm normalized name: Pimecrolimus
DrugBank: Pimecrolimus (DB00337)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral pimecrolimus 30 mg twice daily
Trial: 15948996
Drug: Oral pimecrolimus
RxNorm normalized name: Pimecrolimus
DrugBank: Pimecrolimus (DB00337)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral pimecrolimus 20 mg twice daily
Trial: 15948996
Drug: Oral pimecrolimus
RxNorm normalized name: Pimecrolimus
DrugBank: Pimecrolimus (DB00337)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral pimecrolimus 10 mg twice daily
Trial: 10888946
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (frequently repeated active submaximal movements combined with mechanical diagnosis and therapy)
Trial: 10888946
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (early administration within 96 hours)
Trial: 10888946
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (initial rest, recommended use of a soft collar, gradual self-mobilization)
Trial: 1416808
Drug: Valproate (VPA),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valproate (VPA), 15 mg/kg
Trial: 1416808
Drug: Felbamate (FBM),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felbamate (FBM), 3,600 mg/day
Trial: 29496255
Drug: Tivantinib (360
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tivantinib (360 mg twice daily) plus Erlotinib (150 mg daily)
Trial: 29496255
Drug: Single-agent chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-agent chemotherapy (investigator's choice of pemetrexed, docetaxel, or gemcitabine)
Trial: 29496255
Drug: Single-agent chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-agent chemotherapy (C)
Trial: 18632218
Drug: Oral visual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral visual inspection intervention
Trial: 12192164
Drug: Antimicrobial therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimicrobial therapy (various types)
Trial: 7924477
Drug: Disodium cromoglycate
RxNorm normalized name: Disodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disodium cromoglycate (DSCG), 40 mg
Trial: 31895776
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese Medicine (TCM) individualized treatment
Trial: 21633535
Drug: Water infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water infusion limited to the rectum, sigmoid colon and descending colon
Trial: 16738289
Drug: Vecuronium 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium 0.1 mg.kg(‐1) iv
Trial: 15537991
Drug: Task-oriented physical
RxNorm normalized name: Oriental melon
DrugBank: Muskmelon (DB15611)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Task-oriented physical therapy with rehabilitation technology (treadmill, Kinetron isokinetic exerciser, limb-load monitor)
Trial: 15537991
Drug: Task-oriented physical
RxNorm normalized name: Oriental melon
DrugBank: Muskmelon (DB15611)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Task-oriented physical therapy without rehabilitation technology
Trial: 15537991
Drug: Task-oriented physical
RxNorm normalized name: Oriental melon
DrugBank: Muskmelon (DB15611)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Task-oriented physical therapy (both groups pooled)
Trial: 6362385
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment (crossover group)
Trial: 6362385
Drug: Medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical treatment (medical adherers group)
Trial: 27632557
Drug: Rupatadine 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rupatadine 40 mg
Trial: 27632557
Drug: Rupatadine (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rupatadine (all doses)
Trial: 22295891
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil supplement (2 g containing 600 mg EPA and DHA) for 9 weeks
Trial: 17913001
Drug: CPC/ZG mucoadhesive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPC/ZG mucoadhesive gel
Trial: 17241421
Drug: UV-B irradiation
RxNorm normalized name: Influenza B virus B/Brisbane/60/2008 antigen (UV, formaldehyde inactivated)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UV-B irradiation after BoNT/A injection
Trial: 17241421
Drug: BoNT/A injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BoNT/A injection (100 mU)
Trial: 10926345
Drug: Salmeterol/fluticasone propionate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol/fluticasone propionate combination therapy 50/250 microg twice daily
Trial: 1600111
Drug: Syrup formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Syrup formulations
Trial: 1600111
Drug: Capsule formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsule formulations
Trial: 1600111
Drug: Both dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both dosage forms
Trial: 24641586
Drug: Cholecalciferol treatment
RxNorm normalized name: Cholecalciferol
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholecalciferol treatment
Trial: 28929919
Drug: Functional electrical
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Functional electrical stimulation therapy assisted walking (FES‐T)
Trial: 24092833
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin D₃ 4000 IU/d
Trial: 24092833
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin D₃ 400 IU/d
Trial: 24092833
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin D₃ (all doses)
Trial: 16140508
Drug: One-Stage group
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One-Stage group (n=32) received 12 months of inpatient treatment
Trial: 16140508
Drug: Step-Down group
RxNorm normalized name: Kool-Down
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Step-Down group (n=29) received 6 months of inpatient treatment followed by 12 months of outpatient therapy
Trial: 14530727
Drug: Delayed resection
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed resection after chemotherapy
Trial: 14530727
Drug: Chemotherapy followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chemotherapy followed by resection
Trial: 10720081
Drug: GHRH (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GHRH (100 microg) plus arginine (30 g)
Trial: 9121089
Drug: betapressin (penbutolol)
DrugBank: Penbutolol (DB01359)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: betapressin (penbutolol) 40 mg
Trial: 9121089
Drug: betapressin at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: betapressin at a mean daily dose 108.4 +/- 6.25 mg
Trial: 3965820
Drug: Cardioplegic solution
RxNorm normalized name: cardioplegic solution no.2
DrugBank: Magnesium chloride (DB09407)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cardioplegic solution infused via the aortic root
Trial: 3965820
Drug: Reinfusions of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reinfusions of cardioplegic solution given both centrally and through the completed distal left anterior descending anastomosis
Trial: 27555901
Drug: Locator implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Locator implant attachment
Trial: 24975729
Drug: Intracoronary injection
RxNorm normalized name: HELIUM 992 mL in 1 L INTRACORONARY GAS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracoronary injection with bone marrow mesenchymal stem cells (BMSCs) after PCI
Trial: 19996066
Drug: Treatment to
RxNorm normalized name: Lice Treatment Topical lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment to an average systolic blood pressure of 135 to 145 mm Hg and an average diastolic blood pressure of 60 to 90 mm Hg
Trial: 9726382
Drug: Olsalazine sodium,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olsalazine sodium, 3 g/day
Trial: 9726382
Drug: Mesalazine, 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesalazine, 3 g/day
Trial: 14719987
Drug: Chemotherapy followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chemotherapy followed by radiotherapy
Trial: 2564233
Drug: MC903 cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MC903 cream (1.2 mg MC903 per g cream)
Trial: 28944714
Drug: Placebo lozenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo lozenge
Trial: 31044491
Drug: Low-dose factor
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose factor VIII (FVIII) tertiary prophylaxis, 10 IU/kg body weight, two times per week
Trial: 31044491
Drug: Low-dose factor
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose factor VIII (FVIII) tertiary prophylaxis
Trial: 24589084
Drug: On-demand treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: On-demand treatment
Trial: 25474552
Drug: Heparinized saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparinized saline (10 U ml(-1))
Trial: 10852440
Drug: Alendronate (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate (10 mg daily) after PTH treatment
Trial: 10852440
Drug: PTH (highest
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PTH (highest dose)
Trial: 2895577
Drug: Betaxolol 10
RxNorm normalized name: betaxolol 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betaxolol 10 to 40 mg
Trial: 2895577
Drug: Atenolol 25
RxNorm normalized name: atenolol 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 25 to 100 mg
Trial: 24097273
Drug: Tamsulosin 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.2 mg daily for 4 weeks followed by Tamsulosin 0.2 mg and Solifenacin 5.0 mg daily for 8 weeks (Group 1)
Trial: 24097273
Drug: Tamsulosin 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.2 mg and Solifenacin 5.0 mg combination for 12 weeks (Group 2)
Trial: 17298965
Drug: 6 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 g/day propionyl‐L‐carnitine (PLC) for 7 days
Trial: 9791844
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg Panax ginseng supplementation
Trial: 322273
Drug: Tragant sulfate
RxNorm normalized name: SULFATE
DrugBank: Sulfate ion (DB14546)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tragant sulfate (pepsin inhibitor)
Trial: 31623857
Drug: DL1 (trametinib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DL1 (trametinib 1.5 mg, GSK2141795 50 mg)
Trial: 31623857
Drug: DL-1 (trametinib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DL-1 (trametinib 1.5 mg, GSK2141795 25 mg)
Trial: 27380540
Drug: Siponimod 2
RxNorm normalized name: siponimod 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Siponimod 2 mg
Trial: 27380540
Drug: Siponimod 10
RxNorm normalized name: SIPONIMOD
DrugBank: Siponimod (DB12371)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Siponimod 10 mg
Trial: 21432860
Drug: Azelnidipine 16
RxNorm normalized name: Azelnidipine
DrugBank: Azelnidipine (DB09230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azelnidipine 16 mg once daily
Trial: 15545306
Drug: DOV 216,303
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DOV 216,303 at 150 mg (single dose)
Trial: 15545306
Drug: DOV 216,303
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DOV 216,303 at 100 mg (multiple doses for 10 days)
Trial: 15545306
Drug: DOV 216,303
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DOV 216,303 (single and multiple doses)
Trial: 15545306
Drug: DOV 216,303
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DOV 216,303 (doses > 10 mg)
Trial: 12177637
Drug: Antidepressive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressive treatment (mirtazapine, placebo-controlled); alternative treatment with citalopram if needed.
Trial: 12177637
Drug: Care-as-usual (CAU);
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Care-as-usual (CAU); no treatment offered, psychiatric treatment outside the study recorded.
Trial: 10090926
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of horse antithymocyte globulin (ATG) and cyclosporin (CSA)